4.7 Article

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 81, 期 4, 页码 564-568

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2021-221571

关键词

COVID-19; arthritis; rheumatoid; epidemiology; vaccination; outcome assessment; health care

资金

  1. Research Grant from the Food and Health Bureau, the Government of the Hong Kong Special Administrative Region [COVID19F01]

向作者/读者索取更多资源

This study found no significant association between COVID-19 full vaccination (including mRNA and inactivated virus vaccines) and possible arthritis flare among patients with rheumatoid arthritis. Additionally, there were no significant differences in the distribution of weekly rheumatic drug prescriptions among the three groups of patients since the launch of the vaccination program.
Objectives To investigate the relationship between COVID-19 full vaccination (two completed doses) and possible arthritis flare. Methods Patients with rheumatoid arthritis (RA) were identified from population-based electronic medical records with vaccination linkage and categorised into BNT162b2 (mRNA vaccine), CoronaVac (inactive virus vaccine) and non-vaccinated groups. The risk of possible arthritis flare after vaccination was compared using a propensity-weighted cohort study design. We defined possible arthritis flare as hospitalisation and outpatient consultation related to RA or reactive arthritis, based on diagnosis records during the episode. Weekly prescriptions of rheumatic drugs since the launch of COVID-19 vaccination programme were compared to complement the findings from a diagnosis-based analysis. Results Among 5493 patients with RA (BNT162b2: 653; CoronaVac: 671; non-vaccinated: 4169), propensity-scored weighted Poisson regression showed no significant association between arthritis flare and COVID-19 vaccination ((BNT162b2: adjusted incidence rate ratio 0.86, 95% Confidence Interval 0.73 to 1.01); CoronaVac: 0.87 (0.74 to 1.02)). The distribution of weekly rheumatic drug prescriptions showed no significant differences among the three groups since the launch of the mass vaccination programme (all p values >0.1 from Kruskal-Wallis test). Conclusions Current evidence does not support that full vaccination of mRNA or inactivated virus COVID-19 vaccines is associated with possible arthritis flare.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Novel TCF21high pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix

Xiaobo Li, Jinghua Pan, Tongzheng Liu, Wenqian Yin, Qun Miao, Zhan Zhao, Yufeng Gao, Wei Zheng, Hang Li, Rong Deng, Dandan Huang, Shenghui Qiu, Yiran Zhang, Qi Qi, Lijuan Deng, Maohua Huang, Patrick Ming-Kuen Tang, Yihai Cao, Minfeng Chen, Wencai Ye, Dongmei Zhang

Summary: This study discovered a previously unidentified subset of TPCs, TCF21(high) TPCs, which were associated with liver metastasis in patients with CRC. TCF21 in TPCs increased perivascular ECM stiffness, collagen rearrangement, and basement membrane degradation, establishing a perivascular metastatic microenvironment for colorectal cancer liver metastasis. Furthermore, loss of integrin alpha 5 inhibited the FAK/PI3K/AKT/DNMT1 axis, impairing TCF21 DNA hypermethylation in TCF21(high) TPCs. Overall, this study uncovers a new role of TPCs in haematogenous metastasis and provides potential diagnostic and therapeutic targets for CRC metastasis.
Article Public, Environmental & Occupational Health

Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series

Celine S. L. Chui, Ka Shing Cheung, Jeremy P. Brown, Ian J. Douglas, Ian C. K. Wong, Esther W. Chan, Angel Y. S. Wong

Summary: This study used a self-controlled case series (SCCS) with an active comparator to investigate the association between proton pump inhibitors (PPIs) and the short-term risk of myocardial infarction (MI). The results showed an increased risk of MI following PPI and H(2)RA use, but no significant difference compared with baseline. The elevated risk is likely due to protopathic bias. Further studies are needed to explore the feasibility of using active comparators to address protopathic bias in addition to confounding.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2023)

Article Biochemistry & Molecular Biology

Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022

Kathy Leung, Eric H. Y. Lau, Carlos K. H. Wong, Gabriel M. Leung, Joseph T. Wu

Summary: We tracked the effective reproduction number (R-t) of the Omicron BF.7 variant of SARS-CoV-2 in Beijing from November to December 2022. After China's shift from the zero-COVID policy, R-t increased to 3.44, and the infection incidence peaked on December 11. The cumulative infection attack rate in Beijing was estimated to be 75.7% on December 22, 2022, and 92.3% on January 31, 2023.

NATURE MEDICINE (2023)

Article Transplantation

Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines

Franco Wing Tak Cheng, Carlos King Ho Wong, Simon Xiwen Qin, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, Esther W. Chan, Chi Ho Au, Xuxiao Ye, Sydney Chi Wai Tang, Ian Chi Kei Wong

Summary: A study conducted in Hong Kong using vaccination records found no evidence to suggest an increased risk of glomerular diseases following the BNT162b2 or CoronaVac vaccines.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Letter Infectious Diseases

Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase

Eric Yuk Fai Wan, Boyuan Wang, Sukriti Mathur, Cheyenne I. Ying Chan, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Philip Hei Li, Chak Sing Lau, Ian Chi Kei Wong, Esther Wai Yin Chan

JOURNAL OF INFECTION (2023)

Article Public, Environmental & Occupational Health

Post-acute sequelae of COVID-19 in older persons: multi-organ complications and mortality

Eric Yuk Fai Wan, Ran Zhang, Sukriti Mathur, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Esther Wai Yin Chan, Chak Sing Lau, Ian Chi Kei Wong

Summary: This study evaluates the long-term associations between COVID-19 and risks of multi-organ complications and mortality in older adults. The results show that COVID-19 is significantly associated with cardiovascular, respiratory, neuropsychiatric, renal complications, and all-cause mortality. Thus, infected individuals aged 60 and above may benefit from appropriate monitoring for these complications.

JOURNAL OF TRAVEL MEDICINE (2023)

Article Multidisciplinary Sciences

Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5-17

Francisco Tsz Tsun Lai, Min Fan, Caige Huang, Celine Sze Ling Chui, Eric Yuk Fai Wan, Xue Li, Carlos King Ho Wong, Ching-Lung Cheung, Ian Chi Kei Wong, Esther Wai Yin Chan

Summary: Extending the interval between doses of mRNA Covid-19 vaccines has been linked with a reduced risk of myocarditis in children and adolescents, but impacts on vaccine effectiveness are not known.

NATURE COMMUNICATIONS (2023)

Article Immunology

Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study

Vincent Ka Chun Yan, Franco Wing Tak Cheng, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Carlos King Ho Wong, Xue Li, Eric Yuk Fai Wan, Joshua Sung Chih Wong, Esther Wai Yin Chan, Ian Chi Kei Wong, Mike Yat Wah Kwan, Patrick Ip

Summary: Severe COVID-19 is more common in children and adolescents since the emergence of Omicron. This case-control study in Hong Kong showed that three doses of BNT162b2 or CoronaVac were effective in preventing COVID-19, hospitalizations, and severe outcomes among the pediatric population during the Omicron-dominant pandemic, with increased effectiveness after a booster dose.

EMERGING MICROBES & INFECTIONS (2023)

Article Anesthesiology

Discharge of postoperative patients with an opioid prescription is associated with increased persistent opioid use, healthcare expenditures and mortality: a retrospective cohort study

Xiaodong Liu, Carlos K. H. Wong, Tingting Wu, Eric H. M. Tang, Ivan C. H. Au, Lanlan Li, Chi W. Cheung, Brian H. -H. Lang

Summary: This is a retrospective cohort study investigating the risk factors for persistent opioid use after surgical discharge and the association between opioid prescription at discharge and postoperative emergency department visits, readmission, and mortality. The study found that prescribing opioids on discharge was associated with an increased risk of persistent opioid use, 30-day emergency department visits, 30-day readmission, and 30-day all-cause mortality. Therefore, minimizing opioid prescriptions at discharge could improve perioperative patient outcomes.

BRITISH JOURNAL OF ANAESTHESIA (2023)

Article Immunology

Comparison of Bivalent and Monovalent mRNA Vaccine Boosters

Carlos K. H. Wong, Kristy T. K. Lau, Ivan C. H. Au, Eric H. Y. Lau, Benjamin J. Cowling

Summary: This cohort study conducted in Hong Kong found no significant differences in mortality or hospitalization between individuals who received bivalent and monovalent mRNA as their second booster. Both bivalent and monovalent mRNA boosters provide equal protection against clinical outcomes.

CLINICAL INFECTIOUS DISEASES (2023)

Article Psychiatry

Risks of COVID-19-related hospitalisation and mortality among individuals with mental disorders following BNT162b2 and CoronaVac vaccinations: A case-control study

Hei Hang Edmund Yiu, Vincent K. C. Yan, Yue Wei, Xuxiao Ye, Caige Huang, David J. Castle, Celine S. L. Chui, Francisco T. T. Lai, Xue Li, Carlos K. H. Wong, Eric Y. F. Wan, Ian C. K. Wong, Esther W. Chan

Summary: This study investigated the risks of COVID-19-related hospitalisation and mortality among individuals with mental disorders following one to three doses of BNT162b2 and CoronaVac vaccines. The results showed that two doses of the vaccines significantly reduced the risk of COVID-19-related hospitalisation and mortality, and further protection was provided after three doses. The effectiveness of BNT162b2 vaccine was generally higher than CoronaVac, but the difference diminished after the third dose.

PSYCHIATRY RESEARCH (2023)

Article Medicine, General & Internal

Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study

Xi Xiong, David Tak Wai Lui, Matthew Shing Hin Chung, Ivan Chi Ho Au, Francisco Tsz Tsun Lai, Eric Yuk Fai Wan, Celine Sze Ling Chui, Xue Li, Franco Wing Tak Cheng, Ching-Lung Cheung, Esther Wai Yin Chan, Chi Ho Lee, Yu Cho Woo, Kathryn Choon Beng Tan, Carlos King Ho Wong, Ian Chi Kei Wong

Summary: This study aimed to investigate the risk of incident diabetes following COVID-19 vaccination. The results showed no increased risk of incident diabetes after COVID-19 vaccination. However, SARS-CoV-2 infection was associated with a significantly higher risk of incident diabetes, especially type 2 diabetes.

PLOS MEDICINE (2023)

Article Health Care Sciences & Services

Safety of BNT162b2 or CoronaVac COVID-19 vaccines in patients with heart failure: A self-controlled case series study

Xuxiao Ye, Caige Huang, Yue Wei, Silvia T. H. Li, Vincent K. C. Yan, Kai -Hang Yiu, Hung-Fat Tse, Tiantian Ma, Xiwen Qin, Celine S. L. Chui, Francisco T. T. Lai, Xue Li, Eric Y. F. Wan, Carlos K. H. Wong, Ian C. K. Wong, Esther W. Chan

Summary: This study aimed to investigate the safety of two COVID-19 vaccines, BNT162b2 and CoronaVac, in patients with heart failure (HF). The study found that there were no increased risks of hospitalization for HF, major adverse cardiovascular events (MACE), or all hospitalization after receiving these vaccines in patients with HF.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Review Clinical Neurology

Multimorbidity representation in randomized controlled trials of selective serotonin reuptake inhibitors: A systematic analysis of published trials

Dawn Hei Lum, Mandy Man Choi, Jacky On Hei Cheung, Dora Wai Yee Ng, Janice Ching Nam Leung, Lingyue Zhou, Francisco Tsz Tsun Lai

Summary: This study investigated the representation of multimorbidity in randomized controlled trials (RCTs) of selective serotonin reuptake inhibitors (SSRIs). The results showed that only a minority of RCTs considered multimorbidity, and studies based in Asia were more likely to exclude multimorbidity.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Meeting Abstract Pharmacology & Pharmacy

Risk of carditis among adolescents after extending the interdose intervals of BNT162b2: a nested case-control study

Min Fan, Kuan Peng, Yin Zhang, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Eric Yuk Fai Wan, Carlos King Ho Wong, Esther Wai Yin Chan, Xue Li, Ian Wong

BRITISH JOURNAL OF PHARMACOLOGY (2023)

暂无数据